多基因韧性调节帕金森病遗传风险因素的外显率
研究利用最大规模个体遗传数据计算多基因风险评分,在发现队列和三个验证队列中筛选高遗传风险对照与匹配帕金森病病例,进行全基因组关联分析荟萃分析并构建多基因韧性评分。结果显示较高的多基因韧性评分与较低的帕金森病风险相关(β=-0.054,标准误=0.022,p=0.013),MAGMA基因分析提名TBCA为候选基因,韧性狭义遗传力h2=0.081(标准误=0.035,p=0.0003),功能富集分析提示组蛋白甲基化通路。作者认为遗传韧性评分可调节帕金森病遗传风险因素的外显率,保护高遗传风险个体免于发病。
要点
- 多基因韧性评分较高与帕金森病风险较低相关(β=-0.054,标准误=0.022,p=0.013)。
- 韧性狭义遗传力估计为h2=0.081(标准误=0.035,p=0.0003)。
- MAGMA基因分析提名TBCA为候选基因,功能富集提示组蛋白甲基化通路。
核心结论
- 遗传韧性评分可调节帕金森病遗传风险因素的外显率,保护携带高遗传风险负荷的个体免于发生帕金森病。
研究设计与样本
- 计算多基因风险评分,在发现队列(国际帕金森病基因组学联盟,7204例帕金森病病例和9412例对照)和验证队列(帕金森病遗传与环境综合无偏风险评估,8968例病例和7598例对照;英国生物银行,2639例帕金森病病例和14301例对照;加速药物伙伴关系-帕金森病计划,2248例病例和2817例对照)中识别高遗传风险对照和匹配的帕金森病病例,并对这些个体进行全基因组关联分析荟萃分析。
- 进一步构建多基因韧性评分,并进行基因组注释多标记分析(MAGMA)基于基因的分析和功能富集分析。
主要发现
- 较高的多基因韧性评分与较低的帕金森病风险相关(β=-0.054,标准误=0.022,p=0.013)。
- 没有单个位点达到全基因组显著性,MAGMA基于基因的分析提名TBCA为候选基因。
- 韧性相关的狭义遗传力估计为h2=0.081(标准误=0.035,p=0.0003)。
- 功能富集分析突出组蛋白甲基化作为潜在通路,可能携带减轻帕金森病风险位点效应的韧性等位基因。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of the current study is to understand why some individuals avoid developing Parkinson disease (PD) despite being at relatively high genetic risk, using the largest datasets of individual-level genetic data available. METHODS: We calculated polygenic risk score to identify controls and matched PD cases with the highest burden of genetic risk for PD in the discovery cohort (International Parkinson's Disease Genomics Consortium, 7,204 PD cases and 9,412 controls) and validation cohorts (Comprehensive Unbiased Risk Factor Assessment for Genetics and Environment in Parkinson's Disease, 8,968 cases and 7,598 controls; UK Biobank, 2,639 PD cases and 14,301 controls; Accelerating Medicines Partnership-Parkinson's Disease Initiative, 2,248 cases and 2,817 controls). A genome-wide association study meta-analysis was performed on these individuals to understand genetic variation associated with resistance to disease. We further constructed a polygenic resilience score, and performed multimarker analysis of genomic annotation (MAGMA) gene-based analyses and functional enrichment analyses. RESULTS: A higher polygenic resilience score was associated with a lower risk for PD (β = -0.054, standard error [SE] = 0.022, p = 0.013). Although no single locus reached genome-wide significance, MAGMA gene-based analyses nominated TBCA as a putative gene. Furthermore, we estimated the narrow-sense heritability associated with resilience to PD (h2 = 0.081, SE = 0.035, p = 0.0003). Subsequent functional enrichment analysis highlighted histone methylation as a potential pathway harboring resilience alleles that could mitigate the effects of PD risk loci. INTERPRETATION: The present study represents a novel and comprehensive assessment of heritable genetic variation contributing to PD resistance. We show that a genetic resilience score can modify the penetrance of PD genetic risk factors and therefore protect individuals carrying a high-risk genetic burden from developing PD. ANN NEUROL 2022;92:270-278.
引用
- Liu H, Dehestani M, Blauwendraat C, et al. Polygenic Resilience Modulates the Penetrance of Parkinson Disease Genetic Risk Factors. Ann Neurol. 2022. PMID: 35599344. doi:10.1002/ana.26416
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。